Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival

  • Julia D. Labadie
  • , Sevtap Savas
  • , Tabitha A. Harrison
  • , Barb Banbury
  • , Yuhan Huang
  • , Daniel D. Buchanan
  • , Peter T. Campbell
  • , Steven J. Gallinger
  • , Graham G. Giles
  • , Marc J. Gunter
  • , Michael Hoffmeister
  • , Li Hsu
  • , Mark A. Jenkins
  • , Yi Lin
  • , Shuji Ogino
  • , Amanda I. Phipps
  • , Martha L. Slattery
  • , Robert S. Steinfelder
  • , Wei Sun
  • , Bethany Van Guelpen
  • Xinwei Hua, Jane C. Figuieredo, Rish K. Pai, Rami Nassir, Lihong Qi, Andrew T. Chan, Ulrike Peters, Polly A. Newcomb

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Identification of new genetic markers may improve the prediction of colorectal cancer prognosis. Our objective was to examine genome-wide associations of germline genetic variants with disease-specific survival in an analysis of 16,964 cases of colorectal cancer. We analyzed genotype and colorectal cancer-specific survival data from a consortium of 15 studies. Approximately 7.5 million SNPs were examined under the log-additive model using Cox proportional hazards models, adjusting for clinical factors and principal components. Additionally, we ran secondary analyses stratifying by tumor site and disease stage. We used a genome-wide p-value threshold of 5 × 10–8 to assess statistical significance. No variants were statistically significantly associated with disease-specific survival in the full case analysis or in the stage-stratified analyses. Three SNPs were statistically significantly associated with disease-specific survival for cases with tumors located in the distal colon (rs698022, HR = 1.48, CI 1.30–1.69, p = 8.47 × 10–9) and the proximal colon (rs189655236, HR = 2.14, 95% CI 1.65–2.77, p = 9.19 × 10–9 and rs144717887, HR = 2.01, 95% CI 1.57–2.58, p = 3.14 × 10–8), whereas no associations were detected for rectal tumors. Findings from this large genome-wide association study highlight the potential for anatomical-site-stratified genome-wide studies to identify germline genetic risk variants associated with colorectal cancer-specific survival. Larger sample sizes and further replication efforts are needed to more fully interpret these findings.

Original languageEnglish
Article number127
JournalScientific Reports
Volume12
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival'. Together they form a unique fingerprint.

Cite this